探索MDMA辅助治疗饮食障碍:机制,临床证据和未来的方向
Michael Harkhoe1, Tim Offringa2, Eric Vermetten3
1GG Rivierduinen, Leiden, The Netherlands. m.harkhoe1@rivierduinen.nl.
Journal of eating disorders
|December 30, 2025
概括
MDMA辅助疗法 (MDMA-AT) 通过改善情绪处理和治疗结盟,与其在创伤后应激障碍治疗中的效果相似,对饮食障碍 (EDs) 显示出希望. 需要进一步的研究来验证其在ED群体中的使用.
科学领域:
- 心理药理学 心理药理学
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
背景情况:
- 饮食障碍 (ED),特别是神经性厌食症 (AN),涉及诸如情绪失调和创伤等复杂因素,阻碍了治疗.
- 3,4-甲基二氧化甲胺 (MDMA) 正在研究PTSD,因为它有潜力减少创伤症状并增强治疗效果.
- MDMA可能提供独特的机制来破坏不适应的神经电路,改善认知灵活性,并促进ED的情绪处理.
研究的目的:
- 评估MDMA辅助疗法 (MDMA-AT) 在治疗ED方面的潜力.
- 专注于与MDMA-AT相关的AN和并发性PTSD的神经生物学和心理特征.
- 综合当前关于MDMA,PTSD和ED的研究.
主要方法:
- 关于MDMA,PTSD和ED的当前研究的文献综合.
- 强调临床试验结果,神经生物学机制和治疗框架.
- 对MDMA-AT的药理和心理治疗成分的审查.
主要成果:
- 到目前为止,还没有对ED患者进行MDMA-AT的临床试验.
- 在ED患者中,MDMA的特性 (亲社会,减少恐惧,神经可塑性) 可能会增强情绪处理,治疗联盟和认知灵活性.
- 通过增加情绪开放性和减少恐惧,MDMA可能会改善伴随性创伤的ED患者的参与和结果.
结论:
- 作为ED的辅助治疗,MDMA-AT显得有前途,类似于其在PTSD中的有效性.
- 通过促进情绪处理和对变化的开放,MDMA-AT可能有助于克服ED患者的治疗障碍.
- 严格的试验,道德监督和量身定制的实施策略对于将MDMA-AT整合到ED治疗框架中至关重要.
相关概念视频
Binge Eating Disorders
398
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
398
Modeling in Therapy
356
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
356
Bulimia Nervosa
633
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
633
Anorexia Nervosa
844
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
844
Drug Therapy
226
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
226
Therapeutic Drug Monitoring: Affecting Factors
163
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
163


